article thumbnail

'Appropriate' transition period for COVID-19 test EUAs when public health emergency ends

Healthcare Dive

The FDA is planning to give holders of EUAs for COVID-19 diagnostics and other devices 180 days notice of its intent to end their authorizations, in anticipation of U.S. public health emergency declarations stopping.

COVID-19 307
article thumbnail

DEA and HHS extend virtual prescribing for controlled substances through 2025

Healthcare It News

Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, preventing some patients from losing access to their telehealth-prescribed medications.

COVID-19 309
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could Amtrak’s Quiet Car Be a Model for COVID-19 Travel Policies?

Bill of Health

Amid the ongoing COVID-19 pandemic, this same approach could be taken in relation to masking. A recent study compared COVID-19 spread in Boston-area school districts that dropped mask mandates earlier this year (the majority), with the two much less-resourced school districts that maintained mandates.

COVID-19 363
article thumbnail

Patient messages via Epic increased during COVID-19, raising burnout concerns

Healthcare It News

A research letter published this week in the Journal of the American Medical Association Network Open found that physicians saw a "small but sustained" increase in patient message volume during the first 15 months of the COVID-19 pandemic. At the same time, the message increase did not displace patient calls. ON THE RECORD.

COVID-19 358
article thumbnail

What Happened to the COVID-19 Vaccine Patent Waiver?

Bill of Health

In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. The post What Happened to the COVID-19 Vaccine Patent Waiver?

article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Indeed, as made public, the U.S. Moderna has since made over $30 billion in COVID-19 vaccine sales. By Aparajita Lath.

article thumbnail

COVID-19 vaccine saved millions of lives, study calculates

Healthcare Dive

The vaccines also reduced infections and hospitalizations, which freed up hospital resources, researchers at the Commonwealth Fund and Yale School of Public Health concluded.